To take the CE quiz, click here.
This quiz is open until May 2027.
Kara M. Burns
MS, MEd, LVT, VTS (Nutrition), VTS Hon (Internal Medicine, Dentistry), Editor in Chief
Kara is a licensed veterinary technician with master’s degrees in physiology and counseling psychology. She is the founder and past president of the Academy of Veterinary Nutrition Technicians. Kara is an independent nutritional and wellbeing consultant, and the editor in chief of Today’s Veterinary Nurse. She is a member of many national, international, and state associations and holds positions on many boards in the profession. She has authored numerous articles, textbooks, and textbook chapters and is an internationally invited speaker, focusing on topics of nutrition, leadership, and technician utilization.
Read Articles Written by Kara M. Burns
Protein-losing enteropathy (PLE) is a serious condition in which gastrointestinal disease leads to impaired nutrient absorption and significant loss of plasma proteins, resulting in hypoalbuminemia. Dogs with PLE often have weight loss and other signs of gastrointestinal disease, but these signs may be subtle. Nutritional support to correct negative protein and energy balance is essential in patients with PLE. This article reviews nutritional management as a major component of a multimodal approach to the therapeutic management of dogs with PLE.
Take-Home Points
- In protein-losing enteropathy (PLE), plasma proteins are lost into the gastrointestinal lumen.
- Intestinal lymphangiectasia and alimentary tract lymphoma are the most common causes of PLE in adult dogs.
- Nutritional management based on a nutritional evaluation is imperative to managing a dog with PLE.
- Specific nutrients, including fat and protein, should be adjusted as part of the overall nutritional management of canine PLE.
- Education of the pet owner regarding the serious nature of the disease, the importance of proper management, and the modest potential for a positive outcome is imperative.
Protein-losing enteropathy (PLE) is a syndrome in which plasma proteins are lost into the gastrointestinal (GI) lumen. Any GI disease, if severe enough, can lead to intestinal protein loss; the term PLE broadly encompasses intestinal disorders resulting in GI protein loss so great that hypoalbuminemia results.1 PLE can be the result of inflammatory enteropathies, infectious enteritis, lymphangiectasia, intestinal neoplasia, or small intestinal dysbiosis.2,3 Certain dog breeds appear to be predisposed to PLE (BOX 1).
- Yorkshire terrier
- Soft-coated wheaten terrier (may have concomitant protein-losing nephropathy)
- Chinese Shar-Pei
- Rottweiler
- Norwegian lundehund
In adult dogs, lymphangiectasia and alimentary tract lymphoma are the most common causes of PLE.4 In very young dogs, hookworms and chronic intussusception appear to be more common. If inflammatory bowel disease (IBD) is the cause of PLE, the IBD is typically very severe.4
Causes and Mechanisms of Protein Loss
Although many conditions can result in protein loss through the GI tract, there are a limited number of mechanisms by which plasma protein is lost through the GI tract5:
- Lymphatic obstruction leading to “overflow” lymph leak (e.g., congenital or acquired lymphatic disease)
- Cellular mediator release affecting vascular permeability, resulting in fluid entering tissues (e.g., eosinophilic gastroenteritis)
- Mucosal inflammation (e.g., IBD)
Pathologic dilation of lymphatic vessels in the small intestine, known as intestinal lymphangiectasia, accounts for roughly half of cases of canine PLE.5 Intestinal lymphangiectasia can be congenital; it may also be the result of inflammation and/or hydrostatic pressure changes within veins in the intestine.6,7 Lymphangiectasia leads to PLE by impairing the flow of lymph, which transports fat (in the form of chylomicrons) through lacteals (intestinal lymph vessels) to the systemic circulation. Lymph protein content increases with dietary fat intake,1 and lymph flow increases two- to threefold for 4 to 6 hours postprandially. When lymphatic flow is impaired, lacteals balloon with lymph and can rupture, releasing lymph into the intestinal lumen. The intestinal mucosa is then damaged, with even more protein lost through exudation or hemorrhage into the small intestine.
Clinical Signs of PLE
Clinical signs indicative of PLE are listed in BOX 2. Lymphangiectasia signs may be subtle and often wax and wane over several weeks to months before becoming evident. Clinical manifestations are mostly attributable to the loss of lymph elements or to the inherent GI disease.
- Small intestinal diarrhea (e.g., tenesmus, large fecal volume)
- Vomiting
- Anorexia
- Weight loss
- Pleural effusion
- Ascites
- Peripheral edema secondary to severe hypoalbuminemia
It is important for veterinary healthcare teams to remember that not all dogs present with GI signs. Progressive weight loss, even if the patient has a good appetite, has been reported often in established cases.1 Thus, the team should perform a complete nutritional history, along with body condition scoring and muscle condition scoring, initially and on every subsequent visit.
Nutritional Evaluation of Patients With PLE
Every time an animal presents to the hospital, it should be assessed to establish nutritional needs and feeding goals, which depend on the pet’s physiology and/or disease condition. This is especially true for patients with PLE. The role of the veterinary nurse is to establish patient history, score the patient’s body condition, work with the veterinarian to determine the proper nutritional recommendation for the patient, and communicate this information to the pet owner.
Nutritional History
A nutritional history aids in ascertaining the type or types of food being given to the pet as well as the feeding protocol. The veterinary nurse should ask the owner open-ended questions to uncover more information rather than questions that can be answered with a single word, which may not reveal everything that the patient ingests (BOX 3).
- What does your pet eat over the course of a day?
- Tell me everything that enters your pet’s mouth in a typical day.
- Tell me about any supplements your pet takes.
- Tell me what treats you enjoy giving your pet.
- Tell me about any human foods your pet receives.
- Tell me about medications that are prescribed for your pet.
- How are these medications given to the pet?
- What other pets and other family members are in the household?
- Tell me about your pet’s appetite.
- Tell me about any changes in your pet’s elimination habits.
- Tell me about any pet weight loss that you may have noticed.
The veterinary team member should also ask the owner about the pet’s access to foods, supplements, and medications and how much of each the pet consumes each day. Pets may be fed by multiple family members or receive numerous treats throughout the day. All of these factors play a role in developing a proper nutritional protocol for a patient with PLE.
Body and Muscle Condition Scoring
The healthcare team should document the pet’s body condition score (BCS), muscle condition score (MCS), and weight at every visit as part of the physical examination. The BCS is a subjective assessment that is important when determining whether the patient is at a healthy weight, while the MCS evaluates muscle mass. Assessing muscle condition is important because early identification of muscle loss is beneficial for successful intervention. Together with weight, the BCS and MCS provide consistent measures that can be obtained by all team members.
Client Education
Dogs with PLE do not often have a positive outcome, with only about 50% of cases surviving longer than 4 months.8 Thus, it is imperative for the veterinary team to identify, work to correct, and manage the individual risk factors indicative of a poor outcome (e.g., small intestinal diarrhea, vomiting, anorexia, weight loss) to improve the patient’s odds for survival. As the bridge between veterinarian and client communication and education, the veterinary nurse plays a critical role in the management of these patients by educating clients about the serious nature of the disease, the importance of nutritional management, and the modest potential for a positive outcome.
Nutritional Management of Patients With PLE
Energy balance is an important concept in managing dogs with PLE. Ideally, an animal’s energy intake and expenditure should be equal. However, in dogs with PLE, impaired intestinal absorption of protein lowers the amount of energy obtained from food, often leading to a severe negative protein and energy balance—that is, energy expenditure is higher than energy intake. These animals have subsequent ongoing weight loss and a decrease in lean body tissue as well as fat, making nutritional support essential. Dietary fat intake should be controlled, and, to offset intestinal losses, providing food with a higher protein content may be of benefit.
Digestibility
Feeding highly digestible foods (fat and soluble carbohydrate ≥ 90% digestibility; protein ≥ 87% digestibility1) provides several advantages for managing lymphangiectasia in dogs. Nutrients—especially the energy-supplying nutrients (e.g., fat, carbohydrates, protein)—in highly digestible foods are more readily and completely absorbed in the proximal gut. Highly digestible foods are also associated with:
- Reduced osmotic diarrhea associated with fat and carbohydrate malabsorption
- Reduced intestinal gas production associated with carbohydrate malabsorption
- Decreased antigen loads
- Energy Density and Fat
Nutritional management of intestinal lymphangiectasia focuses on reducing lymphatic pressure by lowering chylomicron formation. This can be achieved through reducing the patient’s fat consumption.6 In many pet foods, fat content comes from long-chain triglycerides. After digestion and lymphatic absorption, long-chain triglycerides are reconstituted into chylomicrons, which are transported from the mucosal epithelium through lacteals as previously described. Because lymph protein content is increased by long-chain triglyceride absorption and lymph flow increases postprandially, it is sensible to limit dietary fat intake (≤ 15 g/1000 kcal) to minimize lymph flow, reduce lacteal and lymphatic distention, and minimize protein loss.1,6
In addition to being balanced, highly digestible, and low fat, diets for dogs with PLE must have sufficient energy density (> 3.5 kcal/g).1 Veterinary teams must remember that patients with PLE may be cachectic; thus, it may be beneficial to include medium-chain triglycerides (MCTs) as a source of calories. MCTs are water soluble and are hydrolyzed readily and rapidly. If MCT oil is warranted, it should be incorporated as an ingredient of a therapeutic food rather than added as a supplement, as the supplement negatively affects palatability. MCT oils do not contain essential fatty acids; thus, the veterinary team must ensure adequate intake of essential fatty acids when MCT oils are used for prolonged periods.
Protein
A PLE patient’s diet should contain enough high-biologic-value proteins to support hepatic protein synthesis and replace depleted tissue proteins.1 Overall, the protein content of food for canine PLE patients should be at least 80 g/1000 kcal. It has been shown that feeding high-protein or all-meat foods without other appropriate dietary alterations does not support a successful outcome for patients with PLE.1,9,10
If severe IBD is the underlying cause of PLE, the veterinary team should consider the use of a low-fat elimination diet containing lower levels of highly digestible, novel protein sources or a hydrolysate-based food. Similarly, if intestinal lymphangiectasia is suspected to be secondary to a food allergy, alternative nutrition strategies such as feeding novel, hydrolyzed, or amino acid protein sources can be implemented.
Tryptophan
Tryptophan, an essential amino acid in dogs, is important in energy metabolism. It is a precursor for kynurenine, serotonin, and melatonin. A small proportion of tryptophan makes its way to the colon, where it is metabolized by luminal bacteria into indole, skatole indicant, and tryptamine, which aid in reducing intestinal inflammation; these metabolites are essential for the induction of anti-inflammatory cytokines such as interleukin-22.11 In dogs with chronic enteropathies, serum amino acids are frequently decreased.8 In dogs with PLE, tryptophan appears to be the only amino acid to be decreased in serum.12 These lower serum tryptophan concentrations correlate with lower serum albumin and poor outcome in dogs with PLE.12 Tryptophan supplementation may have benefit in some PLE cases, but additional research is needed before this becomes standard protocol.
Fiber
Increased levels of insoluble fiber are not typically recommended when managing PLE nutritionally; rather, a total dietary fiber level of 15 g/1000 kcal is recommended.6 Fiber-containing foods do not seem to be directly damaging for patients with PLE, as there are cases in the veterinary literature in which a high-fiber food was successfully fed; however, the food had a low fat content.1,6,13,14
- Dietary fiber at the recommended level of 15 g/1000 kcal is responsible for1:
- Binding digestive enzymes and bile acids
- Decreasing pancreatic secretion of lipase
- Reducing pancreatic enzyme activity
These actions decrease intraluminal fat digestion and micelle formation, which inhibits long-chain fatty acid absorption.13 Consequently, fiber is believed to play a secondary role in reducing long-chain fatty acid absorption, thereby decreasing lymphatic flow and subsequent loss of lymph. However, increased levels of fiber reduce the caloric density and digestibility of a food, which are both considered important to the appropriate management of patients with PLE.1 The recommendation for these patients is lower fiber levels, which support higher caloric density and improved digestibility.
Vitamins
Hypocobalaminemia has been identified to be of similar prognostic importance as hypoalbuminemia in dogs with chronic enteropathies.15 Supplementation with cobalamin can reverse the risk of hypocobalaminemia.15 Cobalamin can be supplemented through weekly subcutaneous injection or orally.
If a commercially prepared food is being fed, vitamin supplementation should not be necessary. In addition, healthy dogs and cats generally have stores of vitamins A, D, E, and K in the body that can last several months. However, as always, the veterinary team needs to continually monitor the patient. If steatorrhea persists, parenteral supplementation with fat-soluble vitamins may be warranted. In cases of long-term fat malabsorption, supplementation of fat-soluble vitamins may be necessary.
Minerals
When fed foods containing higher levels of fat, dogs with an impaired ability to absorb fat may lose increased levels of divalent cations (e.g., calcium, magnesium, zinc, copper) due to intraluminal saponification. Severe hypocalcemia can lead to muscle twitching and contractions (tetany). A decrease in ionized serum calcium concentrations has frequently been reported in dogs with PLE.8,16 Multiple canine PLE studies found ionized hypocalcemia in approximately 10% of all cases.5 One study reported twitching episodes in approximately 60% of Yorkshire terriers with PLE.8,16 These same dogs were found to have significant hypocalcemia and hypomagnesemia, with an accompanying increase in serum concentration of parathyroid hormone.16 Intravenous calcium supplementation should be instituted in dogs with PLE if hypocalcemic tetany develops.1
Likely causes of low serum magnesium levels in dogs with PLE appear to be anorexia and malabsorption, which is further complicated by the use of magnesium-free fluids. If needed, the use of appropriate intravenous fluids to replace magnesium should be considered. Supplementation of other minerals should be carried out if a specific deficiency is found.1
Continuing Care
Following discharge from the hospital, patients with PLE need close monitoring to assess progress or lack thereof. As the owner will need to bring their pet in for these visits at least once a week, the veterinary nurse needs to ensure the relationship between team and owner remains open and honest and, if possible, to teach the owner how to properly weigh their pet and assess BCS and MCS (BOX 4). Each clinical reexamination should include assessment of body weight, BCS, and MCS. A complete nutritional history should be performed at every visit. As part of providing consistent education and client support, the veterinary nurse should be available at these visits to answer questions and aid in explaining any diet or other changes recommended by the veterinarian based on the patient’s progress.
- Body condition score, muscle condition score, and weight: These values are important not only for what they reveal about energy balance and muscle atrophy but also because they are objective data that can be used when communicating with the veterinary team. Early identification of muscle or weight loss can help determine when to adjust the diet to help maintain a positive energy balance.
- Stool quality: Is the stool continuing to be loose and in large amounts, or is it improving?
- Appetite: Does the dog eat enthusiastically, need to be prompted, or need to be hand fed? What are its reactions to the diet being fed?
- Abdomen: Does the abdomen look swollen or pot-bellied? Although a pot-bellied abdomen may look like weight gain, it is more likely distended because of fluid (ascites).
- Breathing: Is the dog breathing normally, or is it having respiratory difficulties?
If the patient’s condition improves, nutritional therapy should be maintained until the underlying enteropathy is resolved; however, complete resolution is rare. Most often, dietary management continues for the lifetime of the pet. With time, it may be possible to increase dietary fat intake; if this is recommended, it should be done gradually and cautiously and only in patients that are not able to maintain ideal body weight or dogs demonstrating evidence of essential fatty acid deficiency.
Summary
PLE in dogs can be a debilitating disease that can be painful for the patient and frustrating for the pet owner and the healthcare team. Nutritional management of PLE is focused on reducing lymphatic pressure by lowering chylomicron formation through reduced fat consumption. Feeding highly digestible foods is advantageous, and the nutritional profile of these foods should support hepatic protein synthesis and replace depleted tissue proteins as well as provide sufficient energy. In cachectic PLE patients, this may include adding MCTs as a source of calories. Dietary fiber, vitamins, and minerals should also be assessed and adjusted as needed. Client education and support are paramount in helping manage patients with PLE, which may require lifelong nutritional therapy.
Digestibility The extent to which nutrients are/can be broken down and absorbed by the body after consumption.
Energy balance The measure of energy expenditure versus energy intake. An animal with neutral energy balance has minimal changes in its store of energy. Animals with a positive energy balance (intake greater than expenditure) may gain weight, while those with a negative energy balance (expenditure greater than intake) may lose weight.
Hepatic protein synthesis The process by which the liver creates plasma proteins, primarily albumin.
Saponification A process by which neutral fats (triglycerides) are broken into glycerol and fatty acids.
References
- Davenport DJ, Jergens AE, Remillard RL. Protein losing enteropathy. In: Hand MS, Thatcher CD, Remillard RL, Roudebush P, Novotny BJ, eds. Small Animal Clinical Nutrition. 5th ed. Mark Morris Institute; 2010:1077-1083.
- Suchodolski JS. Stomach and small intestine. In: Washabau RJ, Day MJ, eds. Canine & Feline Gastroenterology. Elsevier; 2013:177-187.
- Peterson PB, Willard MD. Protein-losing enteropathies. Vet Clin North Am Small Anim Pract. 2003;33(5):1061-1082. doi:10.1016/s0195-5616(03)00055-x
- Couto CG, Nelson RW. Disorders of the intestinal tract: protein losing enteropathy. In: Couto CG, Nelson RW, eds. Small Animal Internal Medicine. 6th ed. Elsevier; 2020:495-498.
- Craven MD, Washabau RJ. Comparative pathophysiology and management of protein-losing enteropathy. J Vet Intern Med. 2019;33(2):383-402. doi:10.1111/jvim.15406
- Rollins A, Murphy M. Nutritional management of protein-losing enteropathy. Todays Vet Pract. 2023;13(4):44-47.
- Jablonski SA. Pathophysiology, diagnosis, and management of canine intestinal lymphangiectasia: a comparative review. Animals (Basel). 2022;12(20):2791. doi:10.3390/ani12202791
- Allenspach K, Iennarella-Servantez C. Canine protein losing enteropathies and systemic complications. Vet Clin North Am Small Anim Pract. 2021;51(1):111-122. doi:10.1016/j.cvsm.2020.09.010
- Finco DR, Duncan JR, Schall WD, Hooper BE, Chandler FW, Keating KA. Chronic enteric disease and hypoproteinemia in 9 dogs. JAVMA. 1973;163(3):262-271.
- Matteeuws D, DeRick A, Thoonen H, Van Der Stock J. Intestinal lymphangiectasia in a dog. J Small Anim Pract. 1974;15(12):757-761. doi:10.1111/j.1748-5827.1974.tb05662.x
- Kathrani A, Lezcano V, Hall EJ, et al. Indoleamine-pyrrole 2,3-dioxygenase-1 (IDO-1) mRNA is over-expressed in the duodenal mucosa and is negatively correlated with serum tryptophan concentrations in dogs with protein-losing enteropathy. PLoS One 2019;14(6):e0218218. doi:10.1371/journal.pone.0218218
- Kathrani A, Allenspach K, Fascetti AJ, Larsen JA, Hall EJ. Alterations in serum amino acid concentrations in dogs with protein-losing enteropathy. J Vet Intern Med. 2018;32(3):1026-1032. doi:10.1111/jvim.15116
- Remillard RL. Dietary management of intestinal lymphangiectasia. Presented at: Seventh Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine; 1989; San Diego, CA:357-358.
- Erickson SL. Dietary management of canine lymphangiectasia. Vet Med. 1988;83:282-286.
- Kimmel SE, Waddell LS, Michel KE. Hypomagnesemia and hypocalcemia associated with protein-losing enteropathy in Yorkshire terriers: five cases (1992- 1998). JAVMA. 2000;217(5):703-706. doi:10.2460/javma.2000.217.703
- Allenspach K, Wieland B, Gröne A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med. 2007;21(4):700-708. doi:10.1892/0891-6640(2007)21[700:ceideo]2.0.co;2
CE Quiz
This article has been submitted for RACE approval for 1 hour of continuing education credit and will be opened for enrollment upon approval. To receive credit, take the test at vetfolio.com. Free registration is required. Questions and answers online may differ from those below. Tests are valid for 2 years from the date of approval.
1. Protein-losing enteropathy (PLE) is a syndrome in which plasma proteins are lost into the gastrointestinal lumen.
a. True
b. False
2. In adult dogs, which of the following is not a cause of PLE?
a. Lymphangiectasia
b. Alimentary tract lymphoma
c. Hookworms
d. All of the above
3. Pathologic dilation of lymphatic vessels in the small intestine, known as __________________, accounts for roughly half of cases of canine PLE.
a. Chylomicronemia
b. Intestinal lymphangiectasia
c. Lymphocytosis
d. Leukemia
4. A PLE patient’s diet should contain enough high-biological-value proteins to:
a. Support hepatic protein synthesis
b. Replace depleted tissue proteins
c. Decrease hepatic protein synthesis
d. A and B
5. In dogs with PLE, which of the amino acids appear to be the only amino acid decreased in serum?
a. Histidine
b. Tryptophan
c. Insoluble fiber
d. Lysine
